KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Albemarle (ALB) EBT (2016 - 2025)

Historic EBT for Albemarle (ALB) over the last 17 years, with Q4 2025 value amounting to -$934.4 million.

  • Albemarle's EBT rose 6090.0% to -$934.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$886.2 million, marking a year-over-year increase of 6886.82%. This contributed to the annual value of -$552.1 million for FY2025, which is 6870.02% up from last year.
  • Albemarle's EBT amounted to -$934.4 million in Q4 2025, which was up 6090.0% from $76.2 million recorded in Q3 2025.
  • In the past 5 years, Albemarle's EBT ranged from a high of $1.2 billion in Q1 2023 and a low of -$2.4 billion during Q4 2024
  • Over the past 5 years, Albemarle's median EBT value was $34.1 million (recorded in 2021), while the average stood at -$45.9 million.
  • As far as peak fluctuations go, Albemarle's EBT crashed by 52520.32% in 2021, and later surged by 1080564.38% in 2022.
  • Albemarle's EBT (Quarter) stood at -$8.1 million in 2021, then surged by 10805.64% to $863.1 million in 2022, then tumbled by 206.7% to -$921.0 million in 2023, then plummeted by 159.5% to -$2.4 billion in 2024, then surged by 60.9% to -$934.4 million in 2025.
  • Its EBT stands at -$934.4 million for Q4 2025, versus $76.2 million for Q3 2025 and -$9.0 million for Q2 2025.